• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机械通气危重症患者艰难梭菌感染:巢式队列研究。

Clostridioides difficile infection in mechanically ventilated critically ill patients: A nested cohort study.

机构信息

Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Farncombe Family Digestive Health Research Institute, McMaster University Hamilton, Ontario, Canada; Department of Health Research Methods, Evaluation and Impact, McMaster University, Canada.

Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada.

出版信息

J Crit Care. 2023 Jun;75:154254. doi: 10.1016/j.jcrc.2023.154254. Epub 2023 Jan 20.

DOI:10.1016/j.jcrc.2023.154254
PMID:36682909
Abstract

INTRODUCTION

Clostridioides difficile infection (CDI) is a serious complication of critical illness. The objective of the study was to determine its incidence, prevalence, timing, severity, predictors, and outcomes.

METHODS

We performed a prospective nested cohort study of CDI within a randomized trial comparing Lactobacillus rhamnosus GG to placebo. We adjudicated cases of CDI using standardized definitions, assessed timing (pre-ICU, in ICU, post-ICU) and severity. We analyzed risk factors and outcomes.

RESULTS

Of 2650 patients, 86 were diagnosed with CDI during 90,833 hospital-days (0.95/1000 hospital-days); CDI prevalence was 3.2%. CDI incidence varied in timing; 0.3% patients had CDI pre-ICU, 2.2% in the ICU; an 0.8% developed CDI post-ICU. Relapse or recurrence of CDI was documented in 9.3% patients. Infections were mild/moderate in severity. Complications included septic shock (26.7%), organ failure (16.3%), and toxic megacolon requiring colectomy (1.2%). No risk factors for CDI were identified. CDI was not associated with hospital mortality. The duration of hospital stay was longer for those who had CDI compared those who did not, CONCLUSION: CDI was uncommon, severity was mild to moderate and not associated with mortality however CDI was associated with a longer hospital stay.

摘要

简介

艰难梭菌感染(CDI)是危重病的严重并发症。本研究的目的是确定其发病率、患病率、时间、严重程度、预测因素和结局。

方法

我们在一项比较鼠李糖乳杆菌 GG 与安慰剂的随机试验中进行了前瞻性嵌套队列研究,以确定 CDI。我们使用标准化定义来判断 CDI 的病例,并评估其时间(入 ICU 前、在 ICU 中、出 ICU 后)和严重程度。我们分析了风险因素和结局。

结果

在 2650 名患者中,90833 个住院日中有 86 名(0.95/1000 住院日)诊断为 CDI;CDI 的患病率为 3.2%。CDI 的发病率在时间上有所不同;0.3%的患者在 ICU 前患有 CDI,2.2%的患者在 ICU 中患有 CDI;0.8%的患者在 ICU 后患有 CDI。9.3%的患者记录了 CDI 的复发或再发。感染的严重程度为轻度/中度。并发症包括感染性休克(26.7%)、器官衰竭(16.3%)和需要结肠切除术的中毒性巨结肠(1.2%)。未确定 CDI 的危险因素。CDI 与住院死亡率无关。与没有 CDI 的患者相比,患有 CDI 的患者的住院时间更长。

结论

CDI 并不常见,严重程度为轻度至中度,与死亡率无关,但与住院时间延长有关。

相似文献

1
Clostridioides difficile infection in mechanically ventilated critically ill patients: A nested cohort study.机械通气危重症患者艰难梭菌感染:巢式队列研究。
J Crit Care. 2023 Jun;75:154254. doi: 10.1016/j.jcrc.2023.154254. Epub 2023 Jan 20.
2
Initial therapy affects duration of diarrhoea in critically ill patients with Clostridioides difficile infection (CDI).初始治疗会影响艰难梭菌感染(CDI)危重症患者腹泻的持续时间。
Crit Care. 2019 Dec 9;23(1):399. doi: 10.1186/s13054-019-2648-6.
3
colonization and the frequency of subsequent treatment for infection in critically ill patients.重症患者的定植情况及后续感染治疗频率。
Infect Control Hosp Epidemiol. 2023 Nov;44(11):1782-1787. doi: 10.1017/ice.2022.240. Epub 2023 Jan 20.
4
Association between Nutrition Protocol with MIYAIRI 588 and Reduced Incidence of Infection in Critically Ill Patients: A Single-Center, Before-and-After Study.营养方案 MIYAIRI 588 与降低危重症患者感染发生率的关联:一项单中心前后对照研究。
Surg Infect (Larchmt). 2022 Jun;23(5):483-488. doi: 10.1089/sur.2022.030.
5
Epidemiology and risk factors for Clostridium difficile infection in critically ill patients in Spain: The PROCRID study.西班牙重症患者艰难梭菌感染的流行病学及危险因素:PROCRID研究
Enferm Infecc Microbiol Clin (Engl Ed). 2018 Apr;36(4):218-221. doi: 10.1016/j.eimc.2017.01.007. Epub 2017 Mar 6.
6
Outcomes of infection in adult cancer and non-cancer patients hospitalised in a tertiary hospital: a prospective cohort study.成人癌症和非癌症患者在一家三级医院住院期间感染的结局:一项前瞻性队列研究。
Eur J Hosp Pharm. 2022 Mar;29(e1):e15-e22. doi: 10.1136/ejhpharm-2020-002574. Epub 2021 Feb 12.
7
The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.布拉氏酵母菌预防治疗对频繁使用易致艰难梭菌感染抗生素的住院患者艰难梭菌医院感染发病率的影响。
Clin Infect Dis. 2021 Nov 2;73(9):e2512-e2518. doi: 10.1093/cid/ciaa808.
8
Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.系统炎症介质是预测艰难梭菌感染不良结局的有效生物标志物。
mBio. 2020 May 5;11(3):e00180-20. doi: 10.1128/mBio.00180-20.
9
Epidemiological and clinical burden of Clostridioides difficile infections and recurrences between 2015 - 2019: the RECUR Germany study.2015 年至 2019 年艰难梭菌感染和复发的流行病学和临床负担:德国 RECUR 研究。
BMC Infect Dis. 2024 Mar 27;24(1):357. doi: 10.1186/s12879-024-09218-y.
10
infection recurrence in the VINCat hospitals: a prospective observational cohort study.VINCat 医院的感染复发:一项前瞻性观察队列研究。
Future Microbiol. 2022 Dec;17:1445-1453. doi: 10.2217/fmb-2022-0076. Epub 2022 Oct 31.

引用本文的文献

1
The Role of Probiotics in the Prevention of Infection in Patients with Chronic Kidney Disease.益生菌在慢性肾脏病患者感染预防中的作用
Nutrients. 2024 Feb 27;16(5):671. doi: 10.3390/nu16050671.